TrialBritish journal of cancer2013

A phase II study of gemcitabine and cisplatin plus sorafenib in patients with advanced biliary adenocarcinomas.

J K Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.